Thrombin Generation
Thrombin Generation - Related Videos
08:01
The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
0 Views •
2026
This protocol describes the Nijmegen Hemostasis Assay, which enables simultaneous, time-resolved measurement of thrombin and plasmin generation to provide an integrated assessment of coagulation and fibrinolysis. The assay aims to improve characterization of hemostatic balance in research and clinical settings beyond the scope of conventional hemostatic tests.
18:30
RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
0 Views •
Cited by 12 •
2013
This protocol presents a complete and detailed procedure to apply RNA-seq, a powerful next-generation DNA sequencing technology, to profile transcriptomes in human pulmonary microvascular endothelial cells with or without thrombin treatment. This protocol is generalizable to various cells or tissues affected by different reagents or disease states.
01:19
DC Generator
0 Views •
2023
An alternator converts mechanical energy into electrical energy that varies sinusoidally, resulting in AC current. Meanwhile, a DC generator converts mechanical energy into electrical energy, which are DC pulses with the same polarity. The construction of a DC generator is similar to that of an alternator, except that the pair of slip rings is replaced by a single split ring, also called a commutator. The commutator functions like a periodic rotary switch; it changes the contacts with the...
01:22
Generation Time
0 Views •
2025
Bacterial generation time, the period required for a bacterial population to double during its exponential growth phase, serves as a critical measure of microbial growth dynamics under optimal conditions. This parameter varies significantly across bacterial species and can be influenced by factors such as temperature, pH, and the availability of nutrients. For example, Escherichia coli can achieve a generation time of approximately 20 minutes, while Mycobacterium tuberculosis exhibits a much...
03:00
Next-generation Sequencing
0 Views •
2021
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold. Next-Generation Sequencing Methods Although all next-generation methods use different technologies, they all share a set of standard features.
FAQs
The prothrombinase complex links the activity of factor Xa and factor Va to efficient thrombin formation from prothrombin. Its position in the cascade helps determine how strongly coagulation progresses after tissue factor has initiated the process. Measuring the resulting thrombin profile therefore captures combined pathway performance rather than focusing on a single clotting factor in isolation.
Thrombin amplifies coagulation because it acts on more than one downstream target. It activates platelets and clotting factors, strengthening the ongoing response, while also converting fibrinogen into fibrin, the material associated with clot formation. This combination makes thrombin generation a functional readout of how initiation, amplification, and fibrin-forming activity work together.
Each parameter highlights a different feature of the coagulation response. Lag time describes the timing of thrombin appearance, peak thrombin indicates the highest measured response, and endogenous thrombin potential summarizes the broader generation profile. Considering these measures together helps investigators evaluate both the timing and strength of coagulation rather than relying on one result.
A thrombin generation assay can integrate effects across coagulation rather than reporting one isolated component. Because it follows the time-dependent response, its readouts reflect the combined behavior of the coagulation system in context. This broader view supports assessment of overall clotting potential and can complement more narrowly focused laboratory evaluations.
In medicine, testing can support assessment of both bleeding disorders and thrombotic disorders, which represent opposite clinical concerns involving hemostasis. The same functional approach can also be used to evaluate the effects of anticoagulants. Its value lies in examining clotting potential through the generated thrombin response across these different clinical settings.
Thrombin generation measurements provide a functional view of a person's clotting potential that can be considered alongside the clinical problem being evaluated. By supporting assessment of bleeding, thrombosis, and anticoagulant effects, the testing may contribute to more individualized approaches to hemostasis management. Its role is therefore especially relevant when overall coagulation behavior matters.